Customize your JAMA Network experience by selecting one or more topics from the list below.
Copyright 2005 American Medical Association. All Rights Reserved. Applicable FARS/DFARS Restrictions Apply to Government Use.2005
Error in Reference List. In the Study by Kreuter et al titled “Pulsed High-Dose Corticosteroids Combined With Low-Dose Methotrexate in Severe Localized Scleroderma,” published in the July issue of the ARCHIVES (2005;141:847-852), the following references were omitted from the reference list. This correction was made previously to online versions of this article.
23. Sato S, Fujimoto M, Kikuchi K, Ihn H, Tamaki K, Takehara K. Soluble CD4 and CD8 in serum from patients with localized scleroderma. Arch Dermatol Res. 1996;288:358-362.
24. Falanga V, Medsger TA Jr, Reichlin M, Rodnan GP. Linear scleroderma: clinical spectrum, prognosis, and laboratory abnormalities. Ann Intern Med. 1986;104:849-857.
25. Heickendorff L, Zachariae H, Bjerring P, Halkier-Sorensen L, Sondergaard K. The use of serologic markers for collagen synthesis and degradation in systemic sclerosis. J Am Acad Dermatol. 1995;32:584-588.
26. Hulshof MM, Bouwes Bavinck JN, Bergman W, et al. Double-blind, placebo-controlled study of oral calcitriol for the treatment of localized and systemic scleroderma. J Am Acad Dermatol. 2000;43:1017-1023.
Error in Reference List in: Pulsed High-Dose Corticosteroids Combined With Low-Dose Methotrexate in Severe Localized Scleroderma. Arch Dermatol. 2005;141(9):1091. doi:10.1001/archderm.141.9.1091
Create a personal account or sign in to: